Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Therapy, Highly Active”

190 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 190 results

Early research (Phase 1)Study completedNCT00879047
What this trial is testing

Interaction of Alcohol and Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS and HIV/AIDS With Hepatitis C Virus (HCV) Co-Infection

Who this might be right for
HIV InfectionsHepatitis C
University of California, San Francisco 30
Early research (Phase 1)Study completedNCT00326716
What this trial is testing

Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women

Who this might be right for
HIV Infection
Bristol-Myers Squibb 69
Testing effectiveness (Phase 2)Study completedNCT00076518
What this trial is testing

The Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV InfectionsHypertriglyceridemia
National Institute of Allergy and Infectious Diseases (NIAID) 100
Not applicableStudy completedNCT00253682
What this trial is testing

Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers

Who this might be right for
Cardiovascular DiseasesHeart DiseasesAtherosclerosis+2 more
University of Miami 167
Large-scale testing (Phase 3)UnknownNCT00437684
What this trial is testing

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy

Who this might be right for
HIV InfectionsHepatitis C
IRCCS San Raffaele 50
Early research (Phase 1)Study completedNCT00107549
What this trial is testing

Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableNot Yet RecruitingNCT07219862
What this trial is testing

Evaluating a Clinical Decision Support Tool for Antiretroviral Therapy Optimization

Who this might be right for
HIV (Human Immunodeficiency Virus)Clinical Decision Support System (CDSS)Antiretroviral Therapy, Highly Active+4 more
Keck School of Medicine of USC 250
Not applicableStudy completedNCT00000922
What this trial is testing

Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,710
Not applicableStudy completedNCT00001075
What this trial is testing

The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Not applicableStudy completedNCT01634477
What this trial is testing

Trends of Morbidity and Mortality Among Thai HIV-infected and HIV-uninfected Patients: a Five-year Prospective Cohort Study

Who this might be right for
HIV InfectionHealthy
Thai Red Cross AIDS Research Centre 816
Post-approval studies (Phase 4)Study completedNCT01192035
What this trial is testing

PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial

Who this might be right for
HIV-1
University of Aarhus 400
Not applicableStudy completedNCT00001131
What this trial is testing

Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Not applicableStudy completedNCT01488942
What this trial is testing

Use of Incentives to Retain Drug Users in HIV Therapy

Who this might be right for
HIV Infection
University of British Columbia 139
Not applicableStudy completedNCT03187964
What this trial is testing

Xpert Ultra and Xpert HIV-VL in People Living With HIV

Who this might be right for
HIV/AIDSTB - TuberculosisAntiretroviral Therapy, Highly Active
University of Stellenbosch 1,053
Not applicableStudy completedNCT00000923
What this trial is testing

Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 110
Early research (Phase 1)Study completedNCT00545558
What this trial is testing

Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV

Who this might be right for
Hepatitis CHIV Infections
University of Cincinnati 18
Early research (Phase 1)Study completedNCT00052182
What this trial is testing

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Not applicableStudy completedNCT01526421
What this trial is testing

Use of Incentives to Engage Drug Users in HIV Therapy

Who this might be right for
HIV Infection
University of British Columbia 301
Testing effectiveness (Phase 2)Study completedNCT00000870
What this trial is testing

A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 200
Not applicableStudy completedNCT00540111
What this trial is testing

Effect of Soluble Fiber on Hypertriglyceridemia and Immune Profile in HIV-positive Individuals.

Who this might be right for
HypertriglyceridemiaHIV Infections
UPECLIN HC FM Botucatu Unesp 19
Load More Results